KAZIMI A J
Transaction: 03/18/2026
BUY
Change
+100,000
Price
$2.80
Filing
03/20/2026
Type
BUY
Cumberland Pharmaceuticals Inc.
CPIX • Drug Manufacturers - Specialty & Generic
Strong market move
CPIX+18.81%
vs. previous close $6.70
$7.96
▲ +1.26 (+18.81%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$119.17M
Growth
5.0%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 5.4%Positive free cash flow · 0.32Consistent free cash flow · 4/5Manageable debt level · 0.41Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.96
Change18.81%
Shares Out14.97M
Market Cap$119.17M
Enterprise Value$115.31M
52W Range1.85 - 8.09
Beta0.11
P/E-10.91
P/S5.34
P/B6.83
P/FCF-48.33
EV/Sales5.17
Price$7.96
Change18.81%
Shares Out14.97M
Market Cap$119.17M
Enterprise Value$115.31M
52W Range1.85 - 8.09
Beta0.11
P/E-10.91
P/S5.34
P/B6.83
P/FCF-48.33
EV/Sales5.17
EV/EBITDA-13.72
EV/FCF-46.77
Earnings Yield-9.16%
FCF Yield-2.07%
Dividend Yield0.00%
Gross Margin85.02%
Oper. Margin-6.27%
Profit Margin-6.37%
Debt/Eq0.41
Current Ratio1.01
Quick Ratio0.84
Revenue 5Y4.98%
FCF 5Y1.92%
Volume41.73K
Avg Volume112.22K
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
50/100
Growth Potential
Revenue and expansion
46/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score▼
Positive revenue growth · 5.4%Positive free cash flow · 0.32Consistent free cash flow · 4/5Manageable debt level · 0.41Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-10-21
80/100
Bullish
Bullish
3
Hold
2
Bearish
0
Insider Transactions
Recent executive and insider activity
Herman James L
Transaction: 03/18/2026
BUY
Change
+2,500
Price
$2.80
Filing
03/20/2026
Type
BUY
Hamm John M.
Transaction: 03/18/2026
BUY
Change
+3,000
Price
$2.80
Filing
03/20/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| KAZIMI A J | BUY | +100,000 | $2.80 | 03/18/2026 | 03/20/2026 |
| Herman James L | BUY | +2,500 | $2.80 | 03/18/2026 | 03/20/2026 |
| Hamm John M. | BUY | +3,000 | $2.80 | 03/18/2026 | 03/20/2026 |
| Bitterman Chris T. | BUY | +3,000 | $2.80 | 03/18/2026 | 03/20/2026 |
| Anthony Todd M. | BUY | +3,000 | $2.80 | 03/18/2026 | 03/20/2026 |
| Young Caroline | BUY | +1,800 | $2.80 | 03/18/2026 | 03/20/2026 |
| Krogulski Kenneth | BUY | +1,800 | $2.80 | 03/18/2026 | 03/20/2026 |
| Jones James | BUY | +1,800 | $2.80 | 03/18/2026 | 03/20/2026 |
| Galante Joseph C | BUY | +1,800 | $2.80 | 03/18/2026 | 03/20/2026 |
| Brown Martin S JR | BUY | +1,800 | $2.80 | 03/18/2026 | 03/20/2026 |
| KAZIMI A J | SELL | -5,845 | $3.06 | 03/16/2026 | 03/18/2026 |
| Krogulski Kenneth | BUY | +62 | $3.91 | 12/31/2025 | 01/06/2026 |
| KAZIMI A J | BUY | +7 | $3.91 | 12/31/2025 | 01/06/2026 |
| Jones James | BUY | +7 | $3.91 | 12/31/2025 | 01/06/2026 |
| Young Caroline | BUY | +5 | $3.91 | 12/31/2025 | 01/06/2026 |
| Krogulski Kenneth | BUY | +54 | $3.94 | 12/30/2025 | 01/06/2026 |
| KAZIMI A J | BUY | +8 | $3.94 | 12/30/2025 | 01/06/2026 |
| Jones James | BUY | +8 | $3.94 | 12/30/2025 | 01/06/2026 |
| Young Caroline | BUY | +2 | $3.94 | 12/30/2025 | 01/06/2026 |
| Krogulski Kenneth | BUY | +54 | $4.01 | 12/29/2025 | 01/06/2026 |